Resveratrol inhibits the migration, invasion and epithelial-mesenchymal transition in liver cancer cells through up- miR-186-5p expression.
10.3724/zdxbyxb-2021-0197
- Author:
Feifeng SONG
1
;
Yiwen ZHANG
1
;
Zongfu PAN
1
;
Qi ZHANG
1
;
Xixuan LU
1
;
Ping HUANG
1
Author Information
1. Department of Pharmacy, Clinical Pharmacy Center, Zhejiang Provincial People's Hospital, Affiliated People's Hospital of Hangzhou Medical College, Hangzhou 310014, China.
- Publication Type:Journal Article
- Keywords:
Epithelial-mesenchymal transition;
Invasion;
Liver neoplasms;
MiR-186-5p;
Migration;
Resveratrol;
experiment
- MeSH:
Cell Line, Tumor;
Cell Movement;
Cell Proliferation;
Epithelial-Mesenchymal Transition;
Gene Expression Regulation, Neoplastic;
Hep G2 Cells;
Humans;
Liver Neoplasms/genetics*;
MicroRNAs/genetics*;
Neoplasm Invasiveness/genetics*;
Resveratrol/pharmacology*
- From:
Journal of Zhejiang University. Medical sciences
2021;50(5):582-590
- CountryChina
- Language:English
-
Abstract:
To investigate the molecular mechanism of resveratrol inhibiting the metastasis of liver cancer . HepG2 and Huh7 cells were treated with different concentrations of resveratrol, and the cell viability was determined by CCK-8 assay to determine the optimal concentration of resveratrol for subsequent experiments. The expressions of miR-186-5p in liver cancer tissues and liver cancer cells were determined by quantitative real-time RT-PCR. The migration and invasion of HepG2 and Huh7 cells were detected by wound healing assay and Transwell assay, and the expression levels of epithelial-mesenchymal transition (EMT) related proteins were determined by Western blotting. Resveratrol with concentration of had no effect on the viability of HepG2 and Huh7 cells, so the concentration of resveratrol in subsequent experiments was 6.25 μmol/L. Resveratrol inhibited the wound healing and invasion of liver cancer cells; increased the expression of E-cadherin, and decreased the expression of vimentin and Twist1. The expression of miR-186-5p was significantly down-regulated in liver cancer tissues and cells compared with the adjacent tissues and normal liver cells (both <0.05). Furthermore, resveratrol induced the expression of miR-186-5p in liver cancer cells (both <0.01). Overexpression of miR-186-5p suppressed the migration, invasion and EMT of liver cancer cells. Knockdown of miR-186-5p blocked the inhibition effects of resveratrol on the migration, invasion and EMT of liver cancer cells. Resveratrol could inhibit the metastasis of liver cancer , which might be associated with up-regulating miR-186-5p.
